This company listing is no longer active
Surgalign Holdings (SRGA.Q) Stock Overview
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spinal hardware implants and biomaterial products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
SRGA.Q Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Surgalign Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.018 |
| 52 Week High | US$4.00 |
| 52 Week Low | US$0.005 |
| Beta | 1.49 |
| 1 Month Change | 63.64% |
| 3 Month Change | -80.00% |
| 1 Year Change | -99.50% |
| 3 Year Change | -99.97% |
| 5 Year Change | -99.99% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| SRGA.Q | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 16.1% | 3.7% | 1.4% |
| 1Y | -99.5% | -19.0% | 19.1% |
Return vs Industry: SRGA.Q underperformed the US Medical Equipment industry which returned -1.8% over the past year.
Return vs Market: SRGA.Q underperformed the US Market which returned 15.2% over the past year.
Price Volatility
| SRGA.Q volatility | |
|---|---|
| SRGA.Q Average Weekly Movement | 40.5% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: SRGA.Q's share price has been volatile over the past 3 months.
Volatility Over Time: SRGA.Q's weekly volatility has increased from 28% to 40% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 240 | Terry Rich | www.surgalign.com |
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spinal hardware implants and biomaterial products worldwide. It offers products for thoracolumbar procedures, including Streamline TL spinal fixation system, a system for degenerative and complex spine procedures; and Streamline MIS spinal fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability.
Surgalign Holdings, Inc. Fundamentals Summary
| SRGA.Q fundamental statistics | |
|---|---|
| Market cap | US$165.30k |
| Earnings (TTM) | -US$50.49m |
| Revenue (TTM) | US$78.12m |
Is SRGA.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SRGA.Q income statement (TTM) | |
|---|---|
| Revenue | US$78.12m |
| Cost of Revenue | US$26.03m |
| Gross Profit | US$52.09m |
| Other Expenses | US$102.58m |
| Earnings | -US$50.49m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.50 |
| Gross Margin | 66.68% |
| Net Profit Margin | -64.63% |
| Debt/Equity Ratio | -54.1% |
How did SRGA.Q perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/10/04 22:18 |
| End of Day Share Price | 2023/10/02 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Surgalign Holdings, Inc. is covered by 12 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Raymond Myers | Benchmark Company |
| Michael Gorman | BTIG |
| William Plovanic | Canaccord Genuity |